Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging

被引：69

作者：

Liang, Steven H. ^{[1
,2
]}

Chen, Jinshan Michael ^{[3
]}

Normandin, Marc D. ^{[1
,2
]}

Chang, Jeanne S. ^{[3
]}

Chang, George C. ^{[3
]}

Taylor, Christine K. ^{[3
]}

Trapa, Patrick ^{[4
]}

Plummer, Mark S. ^{[3
]}

Para, Kimberly S. ^{[3
]}

Conn, Edward L. ^{[3
]}

Lopresti-Morrow, Lori ^{[3
]}

Lanyon, Lorraine F. ^{[3
]}

Cook, James M. ^{[3
]}

Richter, Karl E. G. ^{[3
]}

Nolan, Charlie E. ^{[3
]}

Schachter, Joel B. ^{[3
]}

Janat, Fouad ^{[3
]}

Che, Ye ^{[3
]}

Shanmugasundaram, Veerabahu ^{[3
]}

Lefker, Bruce A. ^{[4
]}

Enerson, Bradley E. ^{[3
]}

Livni, Elijahu ^{[1
,2
]}

Wang, Lu ^{[1
,2
]}

Guehl, Nicolas J. ^{[1
,2
]}

Patnaik, Debasis ^{[6
,7
]}

Wagner, Florence F. ^{[5
]}

Perlis, Roy ^{[5
,6
,7
]}

Holson, Edward B. ^{[5
]}

Haggarty, Stephen J. ^{[6
,7
]}

El Fakhri, Georges ^{[1
,2
]}

Kurumbail, Ravi G. ^{[3
]}

Vasdev, Neil ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Gordon Ctr Med Imaging & Nucl Med & Mol Imaging, Boston, MA 02114 USA

[2] Harvard Med Sch, Dept Radiol, Boston, MA 02114 USA

[3] Pfizer Worldwide Res & Dev, Groton Labs, Eastern Point Rd, Groton, CT 06340 USA

[4] Pfizer Worldwide Res & Dev, 610 Main St, Cambridge, MA 02139 USA

[5] Broad Inst, Stanley Ctr Psychiat Res, 415 Main St, Cambridge, MA 02142 USA

[6] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 185 Cambridge St, Boston, MA 02114 USA

[7] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, 185 Cambridge St, Boston, MA 02114 USA

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2016年 / 55卷 / 33期

关键词：

Alzheimer's disease; glycogen synthase kinase-3; phosphorylation; positron emission tomography; tau proteins; ALZHEIMERS-DISEASE; TRANSGENIC MICE; GSK-3-BETA; RADIOSYNTHESIS; RADIOTRACER; VIVO;

D O I：

10.1002/anie.201603797

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Glycogen synthase kinase-3 (GSK-3) regulates multiple cellular processes in diabetes, oncology, and neurology. N-(3-(1H-1,2,4-triazol-1-yl)propyl)-5-(3-chloro-4-methoxyphenyl)oxazole-4-carboxamide (PF-04802367 or PF367) has been identified as a highly potent inhibitor, which is among the most selective antagonists of GSK-3 to date. Its efficacy was demonstrated in modulation of tau phosphorylation in vitro and in vivo. Whereas the kinetics of PF-367 binding in brain tissues are too fast for an effective therapeutic agent, the pharmacokinetic profile of PF-367 is ideal for discovery of radiopharmaceuticals for GSK-3 in the central nervous system. A C-11-isotopologue of PF-367 was synthesized and preliminary PET imaging studies in non-human primates confirmed that we have overcome the two major obstacles for imaging GSK-3, namely, reasonable brain permeability and displaceable binding.

引用

页码：9601 / 9605

页数：5

共 41 条

[31] Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation [J].

Zhang, Yali ;

Zhang, Jiahui ;

Wang, Enhao ;

Qian, Wei ;

Fan, Yan ;

Feng, Ying ;

Yin, Haimeng ;

Li, Yang ;

Wang, Yuning ;

Yuan, Tianli .

TOXICOLOGICAL SCIENCES, 2018, 162 (02) :475-487

[32] RETRACTED: Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation (Retracted Article) [J].

Zhao, Ruiping ;

Zhang, Zhaoxu ;

Song, Yuejia ;

Wang, Desheng ;

Qi, Jiping ;

Wen, Shirong .

JOURNAL OF ETHNOPHARMACOLOGY, 2011, 133 (03) :1109-1116

[33] Foscarnet, an inhibitor of the sodium-phosphate cotransporter NaPi-IIa, inhibits phosphorylation of glycogen synthase kinase-3β by lithium in the rat kidney cortex [J].

Uwai, Yuichi ;

Kawasaki, Tatsuya ;

Nabekura, Tomohiro .

DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (03) :256-259

[34] Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones [J].

Liang, Zhibin ;

Li, Qing X. .

ACS CHEMICAL NEUROSCIENCE, 2018, 9 (05) :1166-1183

[35] Inhibition of glycogen synthase kinase-3 by BTA-EG4 reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer's disease [J].

Croft, Cara L. ;

Kurbatskaya, Ksenia ;

Hanger, Diane P. ;

Noble, Wendy .

SCIENTIFIC REPORTS, 2017, 7

[36] PHF-TAU FROM ALZHEIMERS BRAIN COMPRISES 4 SPECIES ON SDS-PAGE WHICH CAN BE MIMICKED BY IN-VITRO PHOSPHORYLATION OF HUMAN BRAIN-TAU BY GLYCOGEN-SYNTHASE KINASE-3-BETA [J].

MULOT, SFC ;

HUGHES, K ;

WOODGETT, JR ;

ANDERTON, BH ;

HANGER, DP .

FEBS LETTERS, 1994, 349 (03) :359-364

[37] The New Indirubin Derivative Inhibitors of Glycogen Synthase Kinase-3, 6-BIDECO and 6-BIMYEO, Prevent Tau Phosphorylation and Apoptosis Induced by the Inhibition of Protein Phosphatase-2A by Okadaic Acid in Cultured Neurons [J].

Martin, Ludovic ;

Magnaudeix, Amandine ;

Wilson, Cornelia M. ;

Yardin, Catherine ;

Terro, Faraj .

JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (11) :1802-1811

[38] Structure-activity relationship (SAR) studies on substituted N-(pyridin-3-yl)-2-amino-isonicotinamides as highly potent and selective glycogen synthase kinase-3 (GSK-3) inhibitors [J].

Luo, Guanglin ;

Chen, Ling ;

Jacutin-Porte, Swanee ;

Han, Ying ;

Burton, Catherine R. ;

Xiao, Hong ;

Krause, Carol M. ;

Cao, Yang ;

Liu, Nengyin ;

Kish, Kevin ;

Lewis, Hal A. ;

Macor, John E. ;

Dubowchik, Gene M. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 81

[39] Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry:: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3β [J].

Reynolds, CH ;

Betts, JC ;

Blackstock, WP ;

Nebreda, AR ;

Anderton, BH .

JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1587-1595

[40] A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease [J].

Onishi, Tomohiro ;

Iwashita, Hiroki ;

Uno, Yumiko ;

Kunitomo, Jun ;

Saitoh, Morihisa ;

Kimura, Eiji ;

Fujita, Hisashi ;

Uchiyama, Noriko ;

Kori, Masakuni ;

Takizawa, Masayuki .

JOURNAL OF NEUROCHEMISTRY, 2011, 119 (06) :1330-1340

← 1 2 3 4 5 →